- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06816459
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
Sensory Evaluation of Cigarettes Claiming Removal of Menthol as a Characterizing Flavor
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVE:
I. To convene a consumer panel of adult smokers in New York state (N=24) to assess the smelling properties of a sample of cigarette products sold in the New York and California markets to identify any characterizing flavors.
EXPLORATORY OBJECTIVE:
I. To collate consumer-test findings, highlighting quantitative analysis of any characterizing flavors identified, as well as any qualitative insights from the panel about specific products.
OUTLINE: Participants are randomized to 1 of 2 blocks.
BLOCK ALPHA: Participants complete 3 testing sessions, each session lasting 1 to 2 hours and each session at least 48 hours apart but no more than 1 week apart. Participants undergo the Brief Smell Identification Test (B-SIT) during session 1, a block alpha cigarette smell test with a total of 16 cigarette products during session 2 and a block alpha cigarette taste test with a set of 3 cigarettes during session 3. Testing sessions are completed in the absence of illness or unacceptable toxicity.
BLOCK BETA: Participants complete 3 testing sessions, each session lasting 1 to 2 hours and each session at least 48 hours apart but no more than 1 week apart. Participants undergo the B-SIT during session 1, a block beta cigarette smell test with a total of 16 cigarette products during session 2 and a block beta cigarette taste test with a set of 3 cigarettes during session 3. Testing sessions are completed in the absence of illness or unacceptable toxicity.
Study Type
Enrollment (Estimated)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14263
- Recruiting
- Roswell Park Cancer Institute
-
Contact:
- Richard J. O'Connor
- Phone Number: 716-845-4517
- Email: Richard.OConnor@RoswellPark.org
-
Principal Investigator:
- Richard J. O'Connor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 21-55 years old
- Current daily smoker of factory-made menthol cigarettes
- General good health (assessed by self-rated health item)
- Completion of Brief Smell Identification Test (B-SIT) with no identification of deficits
Exclusion Criteria:
- Daily concurrent use of other tobacco products (e.g., e-cigarettes, cigars, smokeless tobacco)
- Known allergies to mint (peppermint, spearmint), menthol
- Self-reported olfactory or taste deficits
- Pregnant or nursing participants, as indicated by self-report
- History of medications known to interfere with sense of smell
- Positive diagnosis of coronavirus 2019 (COVID-19) within 10 days of enrollment
- Current upper respiratory infection or sinus congestion (e.g., cold, flu, seasonal allergies) (by self report)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Block Alpha (block alpha cigarette tests)
Participants complete 3 testing sessions, each session lasting 1 to 2 hours and each session at least 48 hours apart but no more than 1 week apart.
Participants undergo the B-SIT during session 1, a block alpha cigarette smell test with a total of 16 cigarette products during session 2 and a block alpha cigarette taste test with a set of 3 cigarettes during session 3. Testing sessions are completed in the absence of illness or unacceptable toxicity.
|
Undergo cigarette smell test of 16 cigarettes in vials, then rate the overall smell on a 5 pt scale (not at all, a little noticeable, noticeable, clearly/very noticeable , do not know what this is).
Participants will be present 3 vials , each containing a cigarette and sample in order specified on label, then complete a coolness measure on a 0-100 visual analog scale.
Other Names:
Sensory questionnaires will be administered using a web based application
|
|
Experimental: Block Beta (block beta cigarette tests)
Participants complete 3 testing sessions, each session lasting 1 to 2 hours and each session at least 48 hours apart but no more than 1 week apart.
Participants undergo the B-SIT during session 1, a block beta cigarette smell test with a total of 16 cigarette products during session 2 and a block beta cigarette taste test with a set of 3 cigarettes during session 3. Testing sessions are completed in the absence of illness or unacceptable toxicity.
|
Undergo cigarette smell test of 16 cigarettes in vials, then rate the overall smell on a 5 pt scale (not at all, a little noticeable, noticeable, clearly/very noticeable , do not know what this is).
Participants will be present 3 vials , each containing a cigarette and sample in order specified on label, then complete a coolness measure on a 0-100 visual analog scale.
Other Names:
Sensory questionnaires will be administered using a web based application
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Menthol smell presence
Time Frame: Up to 1 year
|
Will evaluate ratings of menthol smell presence (0-5 scale).
Data will be analyzed under the generalized linear model approach, a flexible regression-based approach that allows for different distributional assumptions of the dependent variable, and for different link functions to describe the relationship between the independent and dependent variable.
These models utilize maximum likelihood (iteratively reweighted least squares) estimation.
The generalized estimating equation extension allows for modeling of sample-averaged repeated measures within individuals.
|
Up to 1 year
|
|
Mint-like smell
Time Frame: Up to 1 year
|
Will evaluate ratings of mint-like smell (0-4 scale).
Data will be analyzed under the generalized linear model approach, a flexible regression-based approach that allows for different distributional assumptions of the dependent variable, and for different link functions to describe the relationship between the independent and dependent variable.
These models utilize maximum likelihood (iteratively reweighted least squares) estimation.
The generalized estimating equation extension allows for modeling of sample-averaged repeated measures within individuals.
|
Up to 1 year
|
|
Cooling sensation during taste test
Time Frame: Up to 1 year
|
Will be assessed using a self-rated coolness measure on a 0-100 visual analog scale.
Data will be analyzed under the generalized linear model approach, a flexible regression-based approach that allows for different distributional assumptions of the dependent variable, and for different link functions to describe the relationship between the independent and dependent variable.
These models utilize maximum likelihood (iteratively reweighted least squares) estimation.
The generalized estimating equation extension allows for modeling of sample-averaged repeated measures within individuals.
|
Up to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
California (CA) version of the test brand cigarette
Time Frame: Up to 1 year
|
Will evaluate proportion correctly identifying the CA version of the test brand cigarette.
|
Up to 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Richard J O'Connor, Roswell Park Cancer Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- I-3571524 (Other Identifier: Roswell Park Cancer Institute)
- NCI-2025-00202 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cigarette Smoking-Related Carcinoma
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingCigarette Smoking-Related CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Institute on Drug Abuse (NIDA)Not yet recruitingCigarette Smoking-Related CarcinomaUnited States
-
Roswell Park Cancer InstituteRecruitingCigarette Smoking-Related CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingMalignant Thoracic Neoplasm | Cigarette Smoking-Related CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingCigarette Smoking-Related CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruiting
-
M.D. Anderson Cancer CenterNational Institute on Drug Abuse (NIDA)CompletedCigarette Smoking-Related CarcinomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); New Mexico State University; National Cancer...WithdrawnCigarette Smoking-Related CarcinomaUnited States
-
University of California, San FranciscoJohns Hopkins University; National Cancer Institute (NCI); University of California... and other collaboratorsCompletedCigarette Smoking-Related CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingCigarette Smoking-Related CarcinomaUnited States
Clinical Trials on Cigarette smell test
-
University of Kansas Medical CenterCompleted
-
University of Kansas Medical CenterEnrolling by invitationTraumatic Brain Injury | Concussion, Brain | Olfactory Disorder | Smell DisorderUnited States
-
Massachusetts General HospitalNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruitingHealthy | Influenza | Anosmia | COVID-19 Respiratory Infection | Asymptomatic COVID-19 | PASC Post Acute Sequelae of COVID 19United States
-
University Medical Center Ho Chi Minh City (UMC)RecruitingParkinson Disease | HyposmiaVietnam
-
University of PennsylvaniaCompleted
-
Penn State UniversityCompletedHealthyUnited States
-
University of GiessenRecruiting
-
Tarsus UniversityCompleted
-
Rockefeller UniversityCompletedSpecific AnosmiasUnited States